Blue MedicareRx Premier (PDP) 2026 Medicare Part D Plan Available in Rhode Island
Blue MedicareRx Premier (PDP) is a Medicare Part D prescription drug plan offered by Blue MedicareRx for the 2027 plan year. This plan is available to residents of Rhode Island and provides outpatient prescription drug coverage, with costs based on premiums, a deductible, and tiered cost-sharing for medications.
Updated: .
| Blue MedicareRx Premier (PDP): Part D Plan Overview | |
|---|---|
| Part D Plan ID: | S2893-003 |
| Plan Year: | 2027 |
| Total Part D Premium: | $284.70 |
| Annual Deductible: | $0.00 |
| Part D Benefit Type: | Enhanced |
| No Deductible Drug Tier: | Not Applicable |
| Low Income Subsidy: | Yes |
| Insured By: | Blue MedicareRx |
Prescription Drug Costs
Blue MedicareRx Premier (PDP) includes prescription drug costs beyond the monthly premium, such as a deductible and tier-based copayments or coinsurance. The tables below show how costs are structured for covered medications under this plan.
Monthly Premium
Blue MedicareRx Premier (PDP) includes a monthly premium for prescription drug coverage. The premium amount for the 2027 plan year is shown below.
| Basic Part D Premium: | $$218.70 |
| Supplemental Part D Premium: | $$66.00 |
| Total Part D Premium: | $$284.70 |
| Low Income Premium Subsidy: | $$33.82 |
| Low Income Premium Subsidy CMS Pays: | $$33.80 |
| Low Income Subsidy Premium: | $$250.90 |
The Low-Income Subsidy (LIS), also known as “Extra Help,” provides financial assistance with Medicare Part D costs for qualifying individuals. See the SSA Extra Help page for details.
Annual Deductible
Blue MedicareRx Premier (PDP) has a $0.00 annual Part D deductible for 2027. This amount must be paid before plan coverage applies to prescriptions.
Out-of-Pocket Costs
Cost-sharing for Blue MedicareRx Premier (PDP) is based on drug tiers, with copayments or coinsurance applied to each tier. The table below summarizes typical out-of-pocket costs.
| Drug Tier | Retail | Mail Order | |
|---|---|---|---|
| Preferred Generic | $1 | $1 | |
| Generic | $7 | $7 | |
| Preferred Brand | $30 | $30 | |
| Non-Preferred Drug | 35% | 35% | |
| Specialty Tier | 33% | 33% | |
| *Deductible does not apply. | |||
CMS Star Ratings
CMS evaluates Medicare Part D plans each year using a 5-star rating system. Ratings reflect plan performance across key measures, including service, satisfaction, and medication safety. See the rating for Blue MedicareRx Premier (PDP) below.
| CMS Measure | Star Rating |
|---|---|
| Overall Plan Rating | |
| Drug Plan Customer Service | |
| Complaints and Changes in the Drug Plan | |
| Member Experience with the Drug Plan | |
| Drug Safety and Accuracy of Drug Pricing |
Contact Information for Blue MedicareRx
| Website: | Blue MedicareRx Plan Page |
|---|---|
| Formulary: | Blue MedicareRx Formulary Page |
| Pharmacy: | Blue MedicareRx Pharmacy Page |
| Prospective Part D Members: | (877)479-2227 |
| Prospective Part D TTY Users: | 711 |
- CMS.gov, Landscape Source Files — Last accessed November 10, 2026
- CMS.gov, Medicare Part C & D Performance — Last accessed November 10, 2026
- CMS.gov, Plan Benefits Package — Last accessed November 10, 2026
- CMS.gov, Monthly Enrollment by Contract/Plan/State/County — Last accessed November 10, 2026
Data sources and methodology documentation..
- Blue MedicareRx (official source), http://www.RxMedicarePlans.com — Last accessed April 27, 2026
- Medicare.gov, "Drug coverage (part D)" — Last accessed May 2, 2026
- Medicare.gov, "What Medicare Part D drug plans cover" — Last accessed May 1, 2026
- CMS.gov, "Understanding True Out-of-Pocket (TrOOP) Costs" — Last accessed May 1, 2026
MedicarePlans.com operates as an independent, non-government informational resource and is not affiliated with or endorsed by the U.S. Government or the federal Medicare program.
Provenance documentation for this data is maintained under the U.S. Core Data for Interoperability (USCDI) Provenance standard.
Page content independently curated and maintained by David W. Bynon, Editorial Steward, using a standardized, data-driven methodology for accurate, non-commercial Medicare plan interpretation and resolution.